SOURCE: Applied DNA Sciences

Applied DNA Sciences

March 25, 2015 19:00 ET

Applied DNA Sciences and Divatex Sign Agreement to Commercialize the World's First Supply Chain-DNA-Verified Cottons

SigNature® T DNA Authentication Solution From Grower to Retailer

STONY BROOK, NY--(Marketwired - March 25, 2015) - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain and product authentication solutions, has entered into a mutual license agreement with Divatex, a leading supplier of home textiles, to commercialize the world's first supply-chain-DNA-verified cotton product. Divatex is responsible for marketing, while APDN licenses its patented SigNature T DNA technology for application to ensure the veracity of the product. Divatex is a wholly-owned subsidiary of Himatsingka Group, India.

"We are excited to use this amazing new innovation to help us deliver a verified, undiluted and authentic proposition to the consumer. It has become increasingly important to our customers that they understand what it is that they are buying, and trust they are getting what they paid for," said David Greenstein, CEO of Divatex.

Using APDN's patented SigNature T DNA technology, US-grown cotton fibers were DNA-tagged at the ginner, enabling all nodes of the supply chain to verify purity along the way. Earlier this year bulk quantities of this year's pima harvest have undergone SigNature T DNA tagging in the San Joaquin Valley in California.

The first finished product made from this tagged fiber will be offered for sale across the US later this year under the PimaCott™ content-branded label.

In addition, APDN expects to license its "On-Site" DNA authentication technology to the suppliers within this retailer's supply chain. Traceability, and authenticity of the cotton supply will be verified as the cotton evolves into finished goods.

Dr. James A. Hayward, CEO of APDN, commented: "The arrangement with Divatex is strategic, retailer-driven, providing the incentive for all supply chain members to participate. Together, we will deliver an unmatched value proposition to retail and consumers in exchange for a new revenue stream from licensing of our core DNA marking technology and our On-Site DNA Authentication services. We will be meeting with many industry brands to demonstrate the platform during NYC market week in which commitments are made for the coming harvest."

About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW. 

Forward-Looking Statement
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly report on Form 10-Q which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contact Information